Xeris Biopharma Holdingsinc Also Known As Xeris Pharmaceuticalsis A Biopharmaceutical Company Founded In 2005 And Based In Delawarethe Company Is Committed To Enhancing Patient Lives By Developing And Commercializing Advanced Pharmaceutical Productsxeris Focuses On Research And Developmentmanufacturingand Marketingutilizing Its Proprietary Technology Platformsxerisol And Xerijectto Reformulate Existing Drugs Into More Convenient And Stable Forms One Of Xeris S Notable Products Is Gvoke Hypopenwhich Received Fda Approval In 2020 For Treating Severe Hypoglycemiathe Company Targets Specific Medical Conditions With Unmet Needssuch As Diabetes Related Hypoglycemia And Cushing S Syndromexeris Biopharma Employs A Dedicated Sales Force In The U Sand Collaborates With Partners In Europe To Expand Its Market Reachin 2022Xeris Merged With Strongbridge Biopharmaenhancing Its Product Portfolio And Aligning With Its Mission To Provide Innovative Pharmaceutical Solutions
No conferences found for this company.
| Company Name | Cortendo Ab |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
